AmberGen is transforming drug development and disease research with its hyper-multiomic mass spectrometric spatial imaging technology. Our MaxOmic™ service lab performs this testing, and we also offer reagents that enable MALDI Mass Spec users to perform such imaging themselves.
Our technology enables the extraction of up to six distinct spatial omics layers from each sample—all on the same instrument. These layers include drug distribution mapping for small molecule drugs (SMDs), antisense oligonucleotides (ASOs), and/or antibody-drug conjugates (ADCs), as well as spatial metabolomics/lipidomics, hyper-plex primary-antibody-targeted proteomics, secondary-antibody-targeted proteomics, targeted transcriptomics, and untargeted or targeted glycomics.
Multimodal imaging—such as H&E or immunofluorescence (IF)—can also be added, all on the same tissue section. As part of our service offering, we provide AI-powered correlative multiomic analysis.
Contact us at Info@AmberGen.com to learn more!
Company Details
- Employees
- 17
- Founded
- -
- Address
- 44 Manning Road,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.AmberGen.com
- HQ
- Billerica, MA
Ambergen Questions
Ambergen's website is http://www.AmberGen.com
Ambergen's LinkedIn profile is https://www.linkedin.com/company/ambergen
Ambergen has
17 employees.
View email and phone details for 17
employees at Ambergen.
Ambergen's industry is
Biotechnology Research
Ambergen's top competitors are
Ambergen Studio,
Lifecanvas Technologies Inc.,
Tissuevision, Inc,
Aspect Analytics,
Vizgen,
Tscan Therapeutics,
10x Genomics,
Bio-Techne,
Akoya Biosciences, Inc.,
Syncell Inc.
Ambergen's categories are Biotechnology Research
Ambergen's founding year is 1993
